Bowles, D W <br/><br/>
Afatinib for the treatment of patients with EGFR-positive non-small cell lung cancer.  [electronic resource] 

 -  Drugs of today (Barcelona, Spain : 1998)  Sep 2013 
 - 523-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1699-3993 
<br/><br/><label>Standard No.: </label>10.1358/dot.2013.49.9.2016610  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Afatinib<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Drug Evaluation, Preclinical<br/>Drug Interactions<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Quality of Life<br/>Quinazolines--adverse effects